Keynote Speakers

Antje Zickler, PhD, is a molecular biologist and senior researcher in Prof. Samir EL Andaloussi’s group at Karolinska Institutet in Stockholm, Sweden. She completed her PhD in molecular cancer genetics in Germany and built a strong foundation in cancer biology and molecular engineering before moving into the rapidly evolving field of EV-based therapeutics. At Karolinska, her work focuses on the engineering of EVs as delivery systems for RNA and protein therapeutics, with a particular emphasis on mRNA cargo loading and functional intracellular delivery. Her research has contributed to the development of pivotal EV-based drug delivery platforms in the EL Andaloussi lab, with fundamental relevance to gene therapy, cancer treatment, and next-generation biologics. 

Marcin Jurga, PhD, currently serves as Chief Scientific Officer at EXO Biologics. With over 15 years of experience leading teams in cell-based regenerative medicine and tissue engineering, Dr. Jurga has heldprominent roles in R&D within biotech companies focused on developing extracellular vesicle (EV) therapeutics since 2011. He has led the scientific direction of EXO Biologics since its inception in 2019. EXO Biologics is recognized as Europe's first clinical-stage biotechnology company to operate its own GMP-certified large-scale EV manufacturing platform, facilitating clinical trials of extracellular vesicles for thetreatment of unmet medical needs. 

Tomás Dias, PhD, is Chief Scientific Officer at Mursla Bio, where he leads the company’s scientific strategy to advance extracellular vesicle omics into next-generation liquid biopsy technologies. He has over 16 years of experience across biosensors, diagnostics, biomarker discovery, clinical studies, and liquid biopsy, including 12 years centralized on extracellular vesicle diagnostics and biomarkers. His work focuses on unlocking the diagnostic potential of tissue-derived extracellular vesicles to enable more precise, non-invasive insights into disease biology. At Mursla Bio, he is helping drive the development of cutting-edge diagnostic solutions that aim to redefine the future of precision medicine. 

Alireza Fazeli is Professor of Comparative Medicine at the Estonian University of Life Sciences, working at the interface of extracellular vesicle biology, reproductive biology, and One Health. His research focuses on the role of extracellular vesicles (EVs) in intercellular communication, reproductive physiology, host–microbiome interactions, and translational applications in both human and veterinary medicine. Alireza Fazeli has an interest in EV-based diagnostics, antimicrobial strategies, and bio-resilience approaches that integrate animal, human, and environmental health. He is actively involved in advancing One Health initiatives and multidisciplinary research networks in the Baltic and European regions. He has authored and co-authored a wide range of scientific publications on EVs, comparative medicine, and translational biomedical research.